Revolutionizing the provision of patient care, improving outcomes and reducing overall cost through new medical technologies is serious business. It takes vision, technical prowess and efficient use of scarce resources in a rigorous regulatory landscape. Last month, The New York Times included the work GCMI and the American Cancer Society are doing with Dr. Darren…
February 14, 2019 (Atlanta, GA) – Georgia Bio, the state’s life science trade association, named GCMI and Rambam Medical Center 2019 Phoenix Award winners. Part of the Georgia Bio’s annual Golden Helix Award program, the Phoenix Award recognizes leaders who have forged academic and industry relationships that will drive translation, leading to new treatments and…
GCMI and the Rambam Health Care Campus, the largest medical center in northern Israel, announce the establishment of a medical technologies accelerator for Israeli-based companies in Atlanta. The agreement, which calls for joint funding, will be formally announced on October 10th at Metro Atlanta Chamber. The accelerator intends to provide promising Israeli medtech startups a…
September 10, 2018 (Atlanta, GA) – The Global Center for Medical Innovation (GCMI) announces it has selected Ares Health Systems as the first digital health startup for its “A1” accelerator program. “We have a well-developed population health solution, but need the commercialization pathway experience and health system relationships GCMI can provide to further prove our…
Boston University’s BOTLab receives $100,000 in endeavor to turn science into commercialized product from American Cancer Society and Global Center for Medical Innovation. Fulfilling its recent commitment to identify, develop, and promote technology innovation within the ACS portfolio of funded research, the American Cancer Society (ACS) and Global Center for Medical Innovation (GCMI) teams have…
On August 14, 2018, GCMI CEO Tiffany Wilson will present before an open public meeting hosted by the U.S. FDA on Pediatric Medical Device Development in Silver Spring, MD. This meeting provides a discussion about strategies to enhance the medical device ecosystem to cultivate development and innovation of devices that serve the unique needs of…
The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 21-25, 2018 in San Diego, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year. Our booth number is 334. We’re excited to spend…
GCMI hosts the fifth cohort of Project Engages Last year, we wrote about the amazing work Georgia Tech Professor Emeritus Dr. Robert Nerem and others are doing with students in six inner-city Atlanta high schools. This year, GCMI had the opportunity to host the fifth Project Engages cohort for an introduction to the medical product…
Mass Device sister publication Drug Delivery Business News reported recently that Clearside Bio, a GCMI client, “has enrolled the first patient in a Phase III trial evaluating its eye drug combined with an intravitreally-administered anti-VEGF agent as a treatment for macular edema associated with retinal vein occlusion.” Reporter Sarah Faulkner goes on to write, “The…
The American Cancer Society (ACS) is partnering with the Atlanta-based Global Center for Medical Innovation (GCMI) to more rapidly bring groundbreaking research from the lab to the clinic. The American Cancer Society conducts research and funds research through grants to hundreds of scientists and health professionals nationwide. Bridging the gap between early research and actual…